PCM
GTHX

Pinz Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Pinz Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-186,515
Closed -$1.42M – 263
2022
Q1 		$1.42M Buy
+186,515
New +$1.77M 0.88% 42

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pinz Capital Management's GTHX Position: Q2 2022 in Review

Pinz Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 186,515 shares — an estimated $1.42M sold.

Pinz Capital Management first reported a position in GTHX in Q1 2022 and held it in 1 quarter. The position peaked at $1.42M in Q1 2022. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • Pinz Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Pinz Capital Management sold 186,515 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $1.42M.
  • Pinz Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Pinz Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $1.42M in Q1 2022.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Pinz Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.